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Hematopoietic stem cells (HSCs) continuously 
generate progenitor cells of distinct lineages, 
  including T, B, NK, dendritic, myeloid, and 
  erythroid cells. Long-term HSCs mature into 
short-term repopulating cells. The short-term re-
populating cell compartment contains multipo-
tent progenitor cells, of which a fraction has the 
ability to diff  erentiate into common lymphoid 
progenitor cells (CLPs) (1–3). Many diff  erent 
bone marrow populations have been proposed to 
seed the adult thymus, including HSCs, multipo-
tent progenitor cells, early lymphoid progenitors, 
and CLPs (1, 2, 4). Thymus-colonizing progeni-
tors in the fetal ages, however, were shown to 
develop from diff  erent origins (5–7).
Once the progenitors enter the thymus 
and interact with Notch ligands expressed on 
the thymic epithelium, T cell development is 
initiated. The earliest T cell precursor cells, 
known as early T-lineage precursors, exhibit 
high expression of c-kit and lack the expres-
sion of the coreceptors CD4 and CD8 (8–10). 
Early T-lineage precursors are present in the 
CD44+CD25− (DN1) subset, which main-
tain the ability to diff  erentiate to diverse cell 
types, including B, NK, and dendritic line-
ages, but have minimal myeloid potential. Pro-
genitor cells become committed to the T cell 
lineage at the CD44+CD25+ (DN2) and the 
CD44−CD25+ (DN3) cell stages.
The E2A gene encodes for two isoforms, 
E12 and E47, generated through alternative 
splicing of exons encoding the DNA binding 
and dimerization domain (11). The E2A pro-
teins are classifi  ed as class I HLH proteins also 
named E proteins (12). They include E12, E47, 
HEB and E2-2, and the Drosophila homologue, 
daughterless. daughterless is most closely related 
to E12 and E47. In B lineage cells, the predom-
inant E-box–binding complex is comprised of 
E47 homodimers, whereas in thymocytes, E47 
readily forms heterodimers with HEB (12, 13).
Thymocyte development is perturbed in 
adult E2A-defi  cient mice, albeit partially, at 
the DN1 stage (14). Enforced expression of 
Id3 in human T-lineage precursor cells and 
expression of a dominant-negative form of 
HEB arrest thymocyte development also at 
the DN stage (15–17). Several target genes, 
including pTα and RAG1/2, have been 
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shown to be regulated by E2A and HEB in developing 
T-lineage cells (18, 19).
T-lineage commitment requires Notch1-mediated signal-
ing (20–26). Four mammalian Notch receptors have been iden-
tifi  ed, designated as Notch1–4. Notch receptors are activated 
upon interacting with diff   erent ligands, named Delta-like 1 
(DL1), Delta-like 3, Delta-like 4, Jagged1, and Jagged2. Bind-
ing of the ligand to the Notch receptor activates proteolytic 
cleavage, resulting in the release of the intracellular portion of 
the receptor (ICN) from the cellular membrane. ICN is trans-
ported to the nucleus, where it interacts with CSL (CBF1, 
RBP-Jκ, suppressor of Hairless Su(H)) to activate down-stream 
target gene expression. Among its targets are Hes1 and pTα (22, 
24). In the thymus, T cell development in Notch1-defi  cient 
mice is blocked at the DN1 stage (27). In contrast, enforced ex-
pression of ICN promotes T cell development in the bone mar-
row, whereas B cell development is perturbed (28). Conditional 
inactivation of the CSL gene and ectopic expression of antago-
nists of Notch signaling, including Deltex1, Nrarp, and Lunatic 
Fringe, inhibit T cell maturation at a similar stage (29–32). 
Consistent with being a key target for Notch1-mediated signal-
ing, thymocyte maturation in Hes1-defi  cient mice is blocked 
at an early stage (33). How Hes1 contributes to T-lineage de-
velopmental progression is still poorly understood.
The critical roles for E proteins and Notch signaling at 
the early stage have raised the question of how these two an-
cient regulatory modules interact to control thymocyte com-
mitment. Initial studies have suggested that Notch signaling 
acts to modulate the transactivation activity of E47 (28, 34). 
Further studies have indicated that enforced Notch signaling 
together with mitogen-activated protein (MAP) kinase sig-
naling readily promotes the degradation of E47, suggesting a 
linear relationship (35, 36). Collectively, these studies suggest 
that E proteins and Notch signaling act in a linear pathway.
Here we show that in vitro E47 and Notch signaling act 
in concert to promote thymocyte development from fetal 
hematopoieitic progenitors. Furthermore, E47 and Notch 
signaling act in synergy in fetal progenitor cells to restrain 
NK and myeloid development. E47 also induces the expres-
sion of a subset of genes involved in Notch-mediated sig-
naling, including Notch3, Hes1, Hes5, Grg6, and, albeit 
modestly, Notch1, and E47 and Notch signaling act synergis-
tically to induce the expression of pTα and CD7. An early 
block of T cell development in E2A-defi  cient fetal thymo-
cytes is rescued, in part, by the overexpression of ICN. Based 
on these and previous observations, we suggest that in the fe-
tal thymus E47 acts to induce the expression of an ensemble 
of genes involved in Notch signaling and additionally that it 
acts in concert with Notch signaling to induce a T lineage–
specifi  c program of gene expression.
RESULTS
Global analysis of gene expression profi  les in E2A-defi  cient 
hematopoietic progenitor cells in response to E47 activity
Previously, we described E2A-defi  cient hematopoietic pro-
genitor cells (HPCs) that exhibit T, NK, dendritic, myeloid, 
and erythroid lineage potential (37). To identify E47 target 
genes in hematopoietic progenitor cells, E2A-defi  cient HPCs 
were transduced with retrovirus carrying an E47–estrogen 
receptor (E47ER) fusion protein. Control cells were trans-
duced with virus carrying the bHLH region but lacking the 
NH2-terminal transactivation domains. Both retroviral con-
structs also contained the coding sequence of hCD25 to   allow 
rapid isolation of transduced cells (Fig. 1 A). 2 d after
infection, the cells were cultured in the presence of S17 stro-
mal cells and incubated with 4-hydroxytamoxifen (4-OHT) 
for a period of 6 h to activate the E47ER fusion protein. 
hCD25-positive cells were purifi  ed using magnetic beads, 
and RNA was isolated (Fig. 1 B). The resulting RNAs were 
converted into cDNA that in turn was used to synthesize 
  biotinylated cRNA, which subsequently was hybridized to 
mouse oligonucleotide arrays. Fluorescence intensities for 
each probe were normalized to the signal from oligonucleo-
tides representing a group of housekeeping genes. The nor-
malized hybridization intensities from each of the samples 
were then compared with that of RNA derived from control 
infected E2A-defi  cient HPCs. We identifi  ed those oligonu-
cleotides that had ratios of either >4.0 (representing candi-
dates for positive regulation by E47) or <0.5 (representing 
genes potentially repressed by E47). We focused our analysis 
on a selected group of genes involved in cell survival, prolif-
eration, and developmental progression. Among this focused 
group of genes, there were 53 whose expression was in-
creased by a factor of at least fourfold (Fig. 1 C). Among 
these were, interestingly, a set of genes that are known to 
play essential roles in T cell development and cell growth, 
including MHC class II, IL-7Rα, syk, pTα, Hes1, LAT, Id2, 
Grg6, Bcl2A1b, CD7, and cyclin D3 (Fig. 1 C). 21 genes 
  repressed by a factor of twofold or more include Bcl11b, 
RORα, and Gfi  1b (Fig. 1 C).
To validate the data obtained from the microarray analysis, 
mRNA was isolated from the transduced cells and analyzed by 
real-time PCR (Fig. 2 A). As predicted from the data obtained 
from the microarray analysis, pTα, IL-7Rα, and LAT tran-
script levels were signifi  cantly elevated in cells expressing E47 
(Fig. 2 B). To determine whether E47 directly activates the 
expression of these target genes, cells were induced with 
4-OHT in the presence of cycloheximide (CHX). Each of the 
targets, including pTα, IL-7Rα, and LAT, were activated in 
the presence of CHX, indicating that the induction of tran-
scription by E47 was direct (Fig. 2 C). These data indicate that 
enforced E47 expression in hematopoietic progenitor cells 
both activates and inhibits the expression of genes associated 
with a T lineage–specifi  c program of gene expression.
E47 activates the expression of an ensemble of genes 
involved in Notch-mediated signaling
Unexpectedly, the bHLH protein, Hes1, was among the tar-
get genes induced by the expression of E47 (Fig. 1). To ex-
plore whether additional components of the Notch signaling 
module are regulated by E47, RNA was analyzed by real-time 
PCR for the expression of Hes1, Hes5, Notch1, Notch2, JEM VOL. 203, May 15, 2006  1331
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Notch3, NumbL, Grg3, Grg6, and Deltex1 (Fig. 2 D). Hes1 
expression was readily induced by E47 activity, as measured 
by real-time PCR, consistent with the data obtained from the 
microarray analysis (Fig. 1). Deltex1, Hes5, and Notch3 were 
also activated by E47. Furthermore, Notch1 expression levels 
were modestly elevated by E47 (Fig. 2 D). Transcript levels of 
Groucho-related corepressors, Grg3 and Grg6, which act 
  together with the Hes gene products to inhibit down-stream 
target gene expression, were also modulated by E47-mediated 
transactivation (Fig. 2 D). The expression of genes involved in 
Figure 1.  E47 target genes expressed in E2A-defi  cient hemato-
poietic progenitor cells. (A) E47ER and bHLHER retroviral constructs. 
The genes encoding E47 and human CD25 are shown. (B) Protocol used 
for enforced overexpression of E47 in E2A-defi  cient HPCs. (C) Target 
genes activated (left) or repressed (right) by the overexpression of E47. 
Values indicated on the horizontal axis show the fold induction or repres-
sion of E47 target transcript levels. Only changes of more than twofold 
for the repression and fourfold for the induction are indicated.1332  LYMPHOCYTE COMMITMENT BY E PROTEINS AND NOTCH SIGNALING | Ikawa et al.
Figure 2.  E47 directly activates in E2A-defi  cient hematopoietic 
progenitor cells the expression of genes involved in Notch-mediated 
signaling. (A) Protocol used to examine regulation of target genes in 
E2A-defi  cient HPCs by E47. (B) pTα, IL-7Rα, and LAT mRNA levels in cells 
either transduced with E47ER or with bHLHER fusion protein. Transcript 
levels were determined using real-time PCR. Shown is the ratio of tran-
script levels of E47ER compared with the bHLHER normalized by the 
acidic ribosomal protein (ARP) mRNA expression. (C) E47 directly regu-
lates pTα, LAT, and IL-7Rα in E2A-defi  cient HPCs. E2A-defi  cient cells were 
treated for a 6-h period in the presence of 4-OHT and CHX. Transcript 
levels were measured using real-time PCR. Indicated is the fold induction 
normalized to the ARP. (D) E47 activates the expression of a subset of 
genes involved in Notch-mediated signaling. Transcript levels were deter-
mined by real-time PCR. Shown is the ratio of transcript levels of E47ER 
compared with bHLHER normalized to the ARP. (E) E47 directly activates 
the expression of a subset of genes involved in Notch-mediated signaling. 
E2A-defi  cient cells were treated for a 6-h period in the presence of 4-OHT 
and CHX. Transcript levels were measured using real-time PCR. Indicated 
is the normalized fold induction. (F) E47 induces the expression of Notch-
associated genes. E47 instead of E47ER fusion protein is transduced in 
E2A-defi  cient cells. Transcript levels were analyzed by real-time PCR after 
24 h of infection. (G) E47 directly regulates the expression of Notch-
  associated genes independent of Notch-mediated signaling. E2A-defi  cient 
cells transduced with E47ER were induced with 4OHT and CHX for 6 h in 
the presence of γ-secretase inhibitor IX. Transcript levels were analyzed 
by real-time PCR and normalized to ARP mRNA levels. (H) Transcript levels 
of pTα, IL-7Rα, and LAT in E2A+/+, E2A+/−, and E2A−/− cells derived from 
fetal day 15 thymocytes. Transcript levels were analyzed by real-time PCR JEM VOL. 203, May 15, 2006  1333
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Notch-mediated signaling was increased by the enforced ex-
pression of E47, even in the presence of CHX, indicating di-
rect regulation by E47 (Fig. 2 E). These data indicate that 
enforced expression of E47 in E2A-defi  cient HPCs rapidly 
leads to the induction or elevation of components of the 
Notch signaling pathway.
To exclude the possibility that the E47ER fusion protein 
aberrantly activates target gene expression, we enforced the 
expression of E47 in the absence of an ER fusion compo-
nent. We found that also in the absence of the estrogen do-
main E47 induces the expression of Hes1, Notch3, and 
Notch1 in E2A-defi  cient HPCs (Fig. 2 F).
Because E2A-defi  cient cells are grown on S17 cells, we 
considered the possibility that Jagged-mediated signaling 
would contribute to the induction of, for example, Hes1 ex-
pression by E47. To exclude this possibility, E2A-defi  cient 
cells transduced with E47ER were cultured in the presence 
of  γ-secretase inhibitor IX. Hes-1, Notch1, and Notch3 
mRNA levels were signifi  cantly induced by E47 in the pres-
ence of the γ-secretase inhibitor IX, indicating that the in-
duction of the expression of these genes was not mediated by 
Notch signaling (Fig. 2 G).
To further defi  ne the involvement of E47 in the regula-
tion of these genes, we examined the expression of these 
genes in fetal E2A+/+, E2A+/−, and E2A−/− thymocytes de-
rived from day 15 embryos. RNA was isolated and analyzed 
by real-time PCR using the appropriate primers. pTα, IL-
7Rα, and LAT transcripts were reduced in E2A-defi  cient 
thymocytes (Fig. 2 H). Hes1, Hes5, Notch1, and Notch3 
transcript levels also were signifi  cantly lower in E2A-defi  -
cient thymi when compared with wild-type thymi (Fig. 2 I). 
E2A heterozygous thymocytes also showed a decrease in 
LAT, pTα, Hes1, and Hes5 mRNA levels as well, indicating 
that the regulation of these genes by E47 is dosage sensitive 
(Fig. 2, H and I). Collectively, these data indicate that in fetal 
thymocytes E2A proteins contribute to the regulation of a 
subset of genes involved in Notch-mediated signaling.
E2A directly regulates Hes1 gene expression
The observations described indicate that, surprisingly, Hes1 
gene expression is activated by E47 in hematopoietic pro-
genitor cells. Because Hes1 activation by E47 occurred in the 
presence of CHX, we conclude that E47 directly regulates 
Hes1 gene expression. The activation of Hes1 by E47 is in-
teresting because it is reminiscent of the regulation of the 
Drosophila homologue of Hes1, enhancer of split, in Drosophila 
sensory organ development (38). Enhancer of split gene 
  expression is regulated by daughterless, a basic helix-loop-
helix (bHLH) protein strikingly similar to E47 (39). To iden-
tify the regulatory elements in the murine Hes1 locus that are 
responsive to E47 binding, we compared the DNA sequence 
of the human, murine, and chicken Hes1 loci. Four domains, 
named CR1-CR4, were identifi  ed that were highly con-
served (Fig. 3 A). One of these conserved elements, CR3, 
contained two E47 high-affi   nity binding sites that are located 
10 bp apart, in both the murine and human sequences, re-
spectively (Fig. 3 A). To determine whether the CR3 ele-
ment has the ability to activate gene expression, we inserted 
it upstream of a minimal promoter linked to the luciferase 
coding region. The reporter construct, as well as a construct 
lacking the CR3 element, was transfected into E2A-defi  cient 
HPCs in the presence of a vector carrying the E47 gene 
placed under control of the β-actin promoter. The reporter 
construct was activated by a factor of 2.5-fold compared with 
the reporter lacking the CR3 region (Fig. 3 C). To deter-
mine whether the increase in luciferase activity was depen-
dent on the E47 binding sites, mutations were generated 
either in one of the sites (named E-box(1) and E-box(2)) or 
in both E-box sites (Fig. 3 B). Mutation of each of the bind-
ing sites substantially lowered luciferase activity (Fig. 3 C). 
These observations indicate that a highly conserved E47 
  responsive regulatory element is present in the Hes1 locus.
Hes1 is normally expressed at the double-negative (DN) 
cell stage but upon β-selection its levels decline signifi  cantly 
(33, 40, 41). To determine whether E47 binds to the CR3 
region in DN and double-positive (DP) cells, we performed 
chromatin immunoprecipitation (ChIP) assay. Thymocytes 
from either wild-type mice or mice harboring a knock-in 
mutation in the E2A locus generating a E2A–GFP fusion 
proteins were sorted, and DN and DP populations were iso-
lated, fi  xed with formaldehyde, and then disrupted by soni-
cation (42). The cross-linked DNA was immunoprecipitated 
using a GFP-specifi  c antibody. Immunoprecipitated DNA 
was amplifi   ed using Hes CR3 primers and examined by 
DNA gel electrophoresis. E47 binding to the Hes1 CR3 ele-
ment was not signifi  cantly enriched in DP thymoctes derived 
from mice expressing the E2A–GFP fusion protein compared 
with wild-type thymocytes (Fig. 3 D). On the other hand, 
the CR3 element was substantially enriched in DN cells in 
E2AGFP mice (Fig. 3, D and E). Because Hes1 transcript 
levels are high in DN thymocytes but virtually absent in DP 
thymocytes, the binding activity of E47 to the Hes1 regula-
tory element correlates with Hes1 gene expression. These 
observations, in conjunction with the induction of Hes1 
  expression by E47 in the presence of CHX (Fig. 2 E), suggest 
that E47 directly regulates Hes1 gene expression by binding 
to a highly conserved regulatory element. These data imply 
that the molecular mechanism underlying enhancer of split 
gene expression has remained conserved in mammalian he-
matopoietic progenitor cells to regulate Hes1 transcription.
and normalized versus ARP. Black bars represent mRNA levels in 
E2A-defi  cient thymocytes. Gray bars represent mRNA levels in E2A+/− 
thymocytes. White bars represent mRNA levels in wild-type thymocytes. 
(G) Transcript levels of Hes1, Hes5, Notch1, and Notch3 in E2A+/+, E2A+/−, 
and E2A−/− thymocytes. RNA was isolated from day 15 fetal thymocytes. 
Transcript levels were analyzed by real-time PCR and normalized versus 
ARP. mRNA levels in E2A-defi  cient (black bars), E2A+/− (gray bars), and 
wild-type (white bars) thymocytes are shown.1334  LYMPHOCYTE COMMITMENT BY E PROTEINS AND NOTCH SIGNALING | Ikawa et al.
Notch-mediated signaling and E47 activate a common 
set of target genes
Previous data have established that Notch signaling activates 
the expression of Hes1 and Hes5 (21–24). Our data indicate 
that E47 directly activates Hes1, Hes5, and Grg6 expression. 
Collectively, the data raise the possibility that Notch signaling 
and E-protein activity act in parallel to induce target gene 
  expression. To identify targets activated by Notch-  mediated 
  signaling alone and in conjunction with E47   expression, E2A-
defi  cient HPCs were transduced with retrovirus carrying the 
E47 bHLH coding sequence. Transduced cells were   cultured 
in the presence of stromal cells expressing the Notch ligand 
DL1 (OP9-DL1) or stromal cells expressing GFP (OP9-GFP) 
for a 6-h period (Fig. 4 A). The hCD25-positive cells were 
subsequently purifi  ed using   magnetic beads, and RNA was 
isolated and analyzed for   diff    erences in down-stream target 
gene expression using microarrays. Interestingly, culturing 
E2A-defi   cient HPCs in the presence of the Notch ligand, 
DL1, showed elevated insulin and olfactory receptor transcript 
levels signifi  cantly within a 6-h period (Fig. 4 A). Additionally, 
GATA-3 and Hes1 mRNA levels were increased, consistent 
with them being targets for Notch-mediated signaling (24, 43). 
Figure 3.  E2A proteins bind to highly conserved E-box sites pres-
ent in a highly conserved Hes1 regulatory element. (A) Alignment of 
human, mouse, rat, and chicken sequences surrounding the Hes1 locus. 
Vertical axis indicates over 50% homology compared with the human 
DNA sequence. Horizontal axis shows where homology is >50%. Four 
regions of substantial homology with chicken DNA sequence is shown, 
designated as CR1-CR4. Bottom panel shows the murine and human DNA 
sequences of the CR3 region. Identical nucleotides are indicated in gray. 
E-box sites are underlined. (B) DNA sequences of wild-type and mutant 
Hes-responsive elements used in transactivation studies are shown. 
(C) Normalized relative luciferase units of activity (RLU) using a dual 
luciferase reporter assay in E2A-defi  cient HPCs transfected with either 
vector alone or expressing E47. Constructs with the mutations in the 
E-box sites are indicated. (D) In vivo occupancy of the E-box sites in the 
Hes1 CR3 region in DN and DP thymocytes derived from wild-type and 
mice carrying an E2A–GFP fusion protein. Input DNA from each prepara-
tion is shown. An anti-GFP antibody was used to immunoprecipitate DNA 
fragments lysed DN and DP cells. DNA samples were serially diluted 
threefold and examined by PCR using primers fl  anking the CR3 region. 
(E) Analysis of E2A binding in vivo to the E-box sites present in the Hes1 
CR3 region. Relative levels were determined using real-time PCR of the 
immunoprecipitated DNA fragments.JEM VOL. 203, May 15, 2006  1335
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Notch signaling also activated the expression of CD7, MHC 
class II, EHOX, FGF21, and IRF7. We note that this set of 
target genes was also activated by the enforced expression 
of E47 alone.
To identify target genes activated by both E47 and Notch 
signaling, E47ER-transduced cells were incubated for 6 h in 
the presence of 4-OHT and OP9-DL1. RNA was isolated 
from the transduced cells and examined by microarray analy-
sis (Fig. 4 B). As expected, E2A-defi  cient cells exposed to 
both Notch signaling and E47 expression induced the ex-
pression of genes including Grg6, LAT, pTα, unc93 homo-
logue, NFκBIε, PirA1, Bmf-pending, EHOX, Notch4, 
CD7, and Hes1, which also responded to either E47 and/or 
Notch-mediated signaling alone (Fig. 4 B). Notch signaling 
and E47 also acted to repress Mmp16, Wnt7b, Egr3, RORα, 
and Ndr1 expression (Fig. 1 and Fig. 4 B).
To examine whether Notch signaling and E47 act in 
  synergy to induce the transcription of this set of genes, RNA 
was isolated from E2A-defi  cient HPCs carrying the E47ER 
  fusion protein cultured in the absence or presence of Notch 
ligand, DL1. mRNA derived from these populations was 
  analyzed by real-time PCR for the expression of Hes1, Hes5, 
pTα, Notch1, Grg3, and Grg6 (Fig. 4 C). As expected Hes1, 
Hes5, Notch1, and Grg6 transcription was activated by both 
E47 and Notch-mediated signaling, although the activation 
of gene expression was not synergistic (Fig. 4 C). However, 
E47 and Notch-mediated signaling acted in synergy to in-
duce the expression of pTα and CD7 (Fig. 4 C). These data 
indicate that E47 activity and Notch signaling in E2A-defi  -
cient HPCs act in parallel pathways to induce the expression 
of a common set of target genes.
Enforced expression of Notch ICN rescues developmental 
arrest in fetal-derived E2A-defi  cient thymocytes
The data described in the previous paragraph suggest that 
E47 activates the expression of several components of the 
Notch signaling pathway and acts in parallel with Notch 
signaling to induce a program of T lineage–specifi  c  gene 
expression. In vivo, thymocyte development in adult 
E2A-defi  cient mice is partially blocked at the DN1 cell stage 
(14). However, a substantial fraction of thymocyte has the 
ability to develop into the mature T cell lineages (14). In 
contrast to adult thymocyte maturation, E2A-defi  cient fetal 
thymocytes ineffi   ciently develop beyond the DN3 cell stage 
(unpublished data).
To determine whether constitutive active Notch signal-
ing has the ability to overcome the impairment of T cell 
  development in E2A-defi   cient fetal progenitors, we used 
a retrovirus vectors expressing ICN in fetal thymocytes. 
  Hematopoietic progenitors derived from either E2A+/+ or 
E2A−/− fetal livers were infected with the retrovirus and 
  cocultured with the deoxyguanosine-treated fetal thymic 
lobes. After 17 d of culture, the cells were harvested and 
  analyzed by fl  ow cytometry. As expected, E2A+/+ progen-
itors infected with control (MigR1) virus diff  erentiated to 
CD4+CD8+ DP thymocytes as well as CD3−NK1.1+ NK 
cells (Fig. 5). On the other hand, E2A−/− progenitors in-
fected with MigR1 virus gave rise to NK cells but failed to 
diff  erentiate into CD3+ and DP cells (Fig. 5). These data are 
consistent with the phenotype of fetal E2A-defi  cient thymo-
cytes that are severely perturbed in their ability to undergo 
T-lineage developmental progression. In contrast, enforced 
expression of ICN in fetal liver progenitor cells restored the 
ability of E2A-defi  cient progenitors to develop into CD3+ 
and DP cells. Collectively, these results indicate that the 
overexpresion of ICN can restore the impairment of T cell 
development of E2A-defi  cient progenitors.
Notch signaling and E47 activity act together 
to promote T-lineage development at the expense 
of NK and myeloid cell maturation
The data shown in Fig. 4 indicate that Notch signaling and 
E47 have the ability to activate the expression of a common 
set of target genes. However, because the abundance of E47 
expression from the retroviral construct is signifi  cantly higher 
than observed in wild-type thymocytes, the data do not pro-
vide unambiguous evidence that E47 and Notch signaling act 
in synergy to induce a T-lineage program of gene expression. 
To examine whether Notch signaling and E47 act in concert 
to promote thymocyte maturation, we cultured progenitors 
derived from E2A+/+, E2A+/−, and E2A−/− fetal liver in the 
presence of OP9-DL1 cells. Furthermore, to inhibit Notch-
mediated signaling the cells were cultured in the presence of 
diff  erent concentrations of γ-secretase inhibitor IX.
E2A+/+ and E2A+/− progenitors effi   ciently  developed 
into DN2 to DN3 stages in the absence of γ-secretase inhibi-
tor (DMSO alone) after 7 d of culture (Fig. 5 A). In contrast, 
E2A−/− progenitors were severely impaired in their ability to 
diff  erentiate into DN3 cells, raising the possibility that the 
ability of these cells to receive Notch signals is perturbed in 
the absence of E2A (Fig. 6 A). Consistent with previous ob-
servations, increasing concentrations of the γ-secretase inhibi-
tor signifi  cantly perturbed thymocyte maturation, resulting at 
10 μM concentration in a complete arrest at the DN1 stage 
(Fig. 6 A) (44). Interestingly, E2A+/− progenitors readily de-
veloped into the DN3 stage (54%) (Fig. 6 A). Similarly, a 
considerable proportion (23%) of E2A+/+ progenitors cul-
tured in the presence of 3 μM γ-secretase inhibitor developed 
into the DN3 stage (Fig. 6 A). However, the majority of 
the E2A+/− cultured in the presence of 3 μM γ-secretase 
  inhibitor was arrested at the DN1 stage and the fraction of 
DN3 cells (6.4%) was severely declined compared with wild-
type thymocytes (23%) (Fig. 6 A). These results suggest that 
Notch signaling and E47 act in concert to promote develop-
mental progression through the DN stage.
To further defi  ne the eff  ect of Notch signaling and E47 
activity in lymphoid development, we also examined the gen-
eration of NK cells. In the E2A+/+ cells, a small number of NK 
cells were found in the absence of the Notch inhibitor (Fig. 6 B).
However, the proportion of NK cells was signifi  cantly 
  increased when cultured in the presence of γ-secretase inhibi-
tors as previously demonstrated (Fig. 6 B) (44). Interestingly, 1336  LYMPHOCYTE COMMITMENT BY E PROTEINS AND NOTCH SIGNALING | Ikawa et al.
Figure 4.  E47 and Notch signaling act in concert to regulate 
down-stream target gene expression in E2A-defi  cient hematopoietic 
progenitor cells. (A) Target genes activated or repressed in E2A-defi  cient 
cells upon exposure to the Notch ligand DL1 for a 6-h period. Values 
  indicated on the horizontal axis show the fold induction (top) or repres-
sion (bottom). Only changes of more than threefold are shown. (B) Target 
genes activated or inhibited in E2A-defi  cient cells upon exposure to the 
Notch ligand DL1 and enforced expression of E47 for a 6-h period. Values 
  indicated on the horizontal axis show the fold induction (top) or repres-
sion (bottom). Only changes of more than fourfold are shown. (C) E47 and JEM VOL. 203, May 15, 2006  1337
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E2A+/− and E2A−/− progenitors gave rise to substantial pro-
portions of NK cells even in the absence of Notch inhibitor 
(Fig. 6 B). Moreover, the proportion and the absolute number 
of the NK cells were synergistically increased in the presence 
of Notch inhibitor in E2A+/− and E2A−/− progenitors (Figs. 
6, B and C). These results suggest that Notch signaling and 
E47 act in concert to initiate T-lineage specifi  cation and to re-
strain fetal hematopoietic progenitors to adopt a NK cell fate.
To examine the eff  ect of myeloid lineage development 
by the combined absence of E2A and Notch signaling, 
we analyzed the generation of Mac1+ cells (Fig. 7). A sub-
stantial fraction of E2A-defi  cient fetal progenitors developed 
into myeloid cells (Fig. 7 A). Interestingly, E2A+/− fetal he-
matopoietic progenitor cells showed an increased ability to 
diff  erentiate into myeloid cells (Fig. 7 A). Strikingly, cultur-
ing E2A+/− progenitors in the presence of γ-secretase inhibi-
tor IX synergistically increased the number of Mac1+ cells 
(Fig. 7 B). We note that the number of Mac1+ cells was sig-
nifi  cantly higher in cells derived from fetal hematopoietic 
E2A+/− compared with E2A−/− progenitors, suggesting that 
the E2A proteins play an essential role in myeloid lineage 
commitment and/or progression (Fig. 7 B).
Collectively these data suggest, in conjunction with the 
data described in the previous section, that in fetal thymocyte 
development E47 acts upstream of an ensemble of genes in-
volved in Notch signaling. In the absence of E47, fetal thy-
mocytes do not have the ability to receive and/or integrate 
Notch-mediated signaling and fail to diff  erentiate into T-lin-
eage cells but allow the development of NK and myeloid 
cells. During subsequent stages of fetal thymocyte matura-
tion, E47 acts in parallel with Notch-mediated signaling to 
promote T-lineage developmental progression.
DISCUSSION
Previous data have indicated that the initial stages of B- and 
T-lineage development require the activities of E proteins. 
These observations have raised the question as to how E pro-
teins infl  uence lineage specifi  cation in both B- and T-lineage 
cells. We propose that in the bone marrow, E proteins by 
themselves in the CLP allow the initiation of a B-lineage pro-
gram of gene expression, whereas in the thymus they act in 
concert with Notch-mediated signaling to induce a T cell fate.
Consistent with a CLP defi  ciency in E2A-defi  cient mice, 
we propose that E2A is transcriptionally active in the CLP 
cell stage (Fig. 8 A) (45). Once E2A is activated it induces the 
expression of a subset of genes that are essential to promote 
B cell development. Among the critical target genes is IL7Rα. 
Specifi  cally, we show that IL-7Rα gene transcription is mod-
ulated by E47 expression. We note, however, that IL-7Rα is 
expressed at substantial levels in E2A-defi  cient HPCs, consis-
tent with its dependence on IL-7 for cell growth (unpub-
lished data). Thus, other factors must contribute to the 
regulation of IL-7Rα expression as well. One such candidate 
is PU.1. PU.1 has been shown to regulate IL-7Rα gene ex-
pression (46). Because PU.1 is expressed at considerable levels 
in E2A-defi  cient HPCs, it is conceivable that E proteins and 
PU.1 act in concert to control the expression of IL-7Rα (Fig. 
8 A). IL7Rα-mediated signaling, E2A and PU.1, in turn acti-
vates EBF transcription, which in turn activates Pax5 (Fig. 
8 A) (47). Once activated EBF and Pax5 then act in concert 
to induce a B-lineage program of gene expression (Fig. 8 A) 
(48). Our data also show that Bcl11a transcript levels were 
modestly elevated by enforced E47 expression. How Bcl11a 
acts in relationship to EBF and Pax5 to promote B cell devel-
opment is an interesting issue that needs to be addressed.
E47 also induces the expression of genes involved in the 
commitment of alternative cell fates, including pTα and 
Notch1. This brings about the question as to how the expres-
sion of these genes is antagonized in B-lineage cells. Pax5 has 
been shown to suppress the transcription of pTα and Notch1 
Notch-mediated signaling act in concert to activate pTα gene expression 
in E2A-defi  cient progenitor cells. Transcript levels were analyzed by real-
time PCR and normalized versus ARP. Black bars represent mRNA levels in 
E2A-defi  cient HPCs expressing E47 and exposed to Notch signaling. Dark 
gray bars represent mRNA levels in E2A-defi  cient HPCs expressing E47. 
Light gray bars represent mRNA levels in E2A-defi  cient HPCs exposed to 
Notch signaling. White bars represent mRNA levels in E2A-defi  cient HPCs 
cultured in the presence of OP9-GFP cells.
Figure 5.  Rescue of T cell development in E2A-defi  cient fetal pro-
genitors upon enforced expression of Notch-IC. Lin− fetal liver pro-
genitors were transduced with control (MigR1) and Notch-IC (ICN) 
retroviral vectors and cultured with the deoxyguanosin-treated fetal thy-
mic lobes (C57BL/6) for 17 d. Thymocytes were analyzed by fl  ow cytom-
etry for the expression of GFP, CD4, CD8, CD3, and NK1.1. The numbers in 
the histograms and quadrants represent the percentage of the cells. The 
data are representative of three independent experiments.1338  LYMPHOCYTE COMMITMENT BY E PROTEINS AND NOTCH SIGNALING | Ikawa et al.
(2, 49). Thus, Pax5 functions to both activate and maintain 
gene expression of a subset of B lineage–specifi  c genes and, 
additionally, may function to repress transcription of non–B 
lineage–specifi  c genes that we suggest are activated by at least 
in part by E2A. Collectively, we propose a genetic regulatory 
network in which E2A, Bcl11a, PU.1, EBF, and Pax5 act in 
linear and parallel pathways to initiate, repress, and maintain 
B lineage–specifi   c gene transcription, promoting commit-
ment of the CLP in the bone marrow environment to the 
B cell fate (Fig. 8 A).
The data demonstrate that E47 and the Notch signaling 
module interact at two distinct levels in fetal hematopoietic 
progenitors: (a) E47 acts to induce the expression of genes 
involved in Notch signaling, including Hes1, Hes5, Grg6, 
Notch3 and Notch1; (b) E47 acts in concert with Notch 
signaling to synergistically induce the expression of pTα and 
CD7 (Fig. 8 B). The induction of an ensemble of genes in-
volved in Notch signaling by E47 is consistent with a block in 
thymocyte development before the onset of T-lineage com-
mitment in E2A-defi  cient fetal thymocytes. We propose that 
this block is caused at least, in part, by an inability of these 
cells to receive Notch and/or integrate Notch signals. During 
later stages of fetal thymocyte development, E47 and Notch 
signaling act in a parallel pathway to promote T-lineage mat-
uration. It will be important to determine whether similar 
mechanisms operate in adult thymocyte development.
Previous studies have suggested a direct link involving 
Notch and E2A. Notch signaling has been demonstrated to 
Figure 6.  E47 and Notch signaling act in concert to promote T cell 
development. Lin− progenitors (105 cells) derived from E14 E2A+/+, 
E2A+/−, and E2A−/− fetal livers were cultured on OP9-DL1 cells for 7 d 
with DMSO alone or in the presence of γ-secretase inhibitor IX at the 
indicated concentrations. (A) Flow cytometry analysis indicating the ex-
pression of CD25 and CD44 of fetal liver cells cultured on OP9-DL1 cells. 
The percentages of the number of cells present in the various compart-
ments are indicated. (B) Flow cytometry analysis indicating CD19 and 
NK1.1 expression of cultured cells on OP9-DL1 cells. The percentages of 
the number of cells present in the quadrants are shown. (C) Total number 
of NK cells generated from 105 Lin− cells of E2A+/+, E2A+/−, and E2A−/− 
fetal livers cultured for 7 d on OP9-DL1 cells at the indicated concentra-
tion of γ-secretase inhibitor. The data are representative of three inde-
pendent experiments.JEM VOL. 203, May 15, 2006  1339
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alter the transactivation activity of E47 (28, 34). Further stud-
ies have demonstrated that Notch-mediated signaling pro-
motes the degradation of E47 upon MAP kinase–dependent 
phosphorylation (35, 36). Both studies suggest a linear path-
way in which Notch-mediated signaling acts upstream of 
E-protein activity. However, we note that synergistic activa-
tion of pTα and CD7 expression by E47 and Notch signals is 
diffi   cult to reconcile with a linear relationship. We note that 
binding sites for E47 and CSL have been identifi  ed in the 
regulatory elements of the pTα chain gene regulatory ele-
ments (50, 51). E47 has been demonstrated to bind directly 
to these enhancer elements using ChIP assays (19). How then 
can we reconcile a linear versus parallel relationship involving 
E47 and Notch-mediated signaling? Our data do not exclude 
the possibility that Notch signaling infl  uences E2A activity in 
developing DN thymocytes. For example, it is conceivable 
that Notch signaling aff  ects the transactivation activity of E47 
while acting in parallel to modulate down-stream target gene 
expression. Likewise, it is plausible that Notch signaling in 
conjunction with MAP kinase signaling at the DN3 and 
DN4 cell stage acts to promote the degradation of E47, re-
sulting in lower E47 proteins levels. We note that a recent 
report has documented that Notch signaling has the ability to 
overcome the block in β-selection in mice that carry muta-
tions causing defects in pre-TCR signaling (52). Neverthe-
less, it will be important to assess the role of Notch signaling 
in modulating E2A-mediated transactivation and altered sta-
bility in the context of endogenous gene expression.
We show here that E2A proteins act to induce the ex-
pression of members of the Hes family, independent of Notch 
signaling. Several studies have provided evidence for a Notch-
independent mechanism of Hes1 and Hes5 gene regulation. 
CSL-defi  cient mice express Hes1 and Hes5 levels in DN thy-
mocytes that are similar to that of wild-type mice (53). Pax5-
defi  cient pro–B cells also express substantial levels of Hes1 
even in the absence of Notch signaling (43). Hes1 transcripts 
have been detected in fetal liver precursors, suggesting that 
Notch signaling was active prethymically (54). Because E47 
is expressed at high levels in fetal liver progenitors, it is con-
ceivable that Hes-1 expression in fetal liver progenitor cells is 
independent of Notch signaling. Thus, a role for Notch sig-
naling in controlling Hes1 expression prethymically needs to 
be reevaluated. Similarly, Hes1 transcription in neuroepithe-
lial cells is activated before the expression of Notch and Delta 
ligands, indicating a mechanism of regulation independent of 
Notch-mediate signaling (55). E47 is expressed in the neuro-
epithelium, and it is conceivable that also in the neuroepithe-
lium Hes1 is regulated by E-protein activity (56).
The activation of Hes1 and Hes5 by the parallel activities 
of E47 and Notch signaling is intriguing because a similar 
regulatory network regulates Drosophila sensory organ dev-
elopment and notochord-specifi   c gene expression in the 
  as  cidian Ciona intestinalis (38, 57). In fl  ies, sensory organ de-
velopment is mediated in part by Notch signaling and bHLH 
activity, which act in parallel to regulate the expression of the 
enhancer of split complex (Fig. 8 C) (38, 57). The bHLH ac-
tivity in peripheral nervous system development is mediated 
by the proneural proteins, achaete and scute, that bind as het-
erodimers with daughterless, to sites present in an enhancer 
controlling the expression of the enhancer of split complex. 
We note that daughterless is closely related to the E2A pro-
teins. Thus, the enhancer of split gene and its homologue in 
mammalian organisms, Hes1, are both regulated by the com-
bined activities of Notch-mediated signaling and bHLH ac-
tivity (57, 58). Notch signaling and HLH activity also regulate 
Figure 7.  E47 and Notch signaling act in concert to induce T cell 
commitment at the expense of myeloid lineage development. Lin− 
progenitors (105 cells) derived from E14 E2A+/+, E2A+/−, and E2A−/− fetal 
livers were cultured on OP9-DL1 stromal cells for 7 d with DMSO alone or 
in the presence of γ-secretase inhibitor IX at the indicated concentra-
tions. (A) Flow cytometry analysis indicating the expression of Mac1 and 
CD19. The percentages of the number of cells present in the various com-
partments are indicated. (B) Total number of Mac1+ cells generated from 
105 Lin− cells of E2A+/+, E2A+/−, and E2A−/− fetal livers cultured for 7 d 
on OP9-DL1 cells at the indicated concentration of γ-secretase inhibitor.1340  LYMPHOCYTE COMMITMENT BY E PROTEINS AND NOTCH SIGNALING | Ikawa et al.
tissue-specifi  c gene expression in the notochord-specifi  c en-
hancer located in the Brachyuri gene of the ascidian Ciona in-
testinalis (57). It is plausible that an ancient basic mechanism 
underlying notochord-specifi  c gene expression in ascidians 
and  Drosophila sensory organ development has been con-
served in mammalian organisms to promote T-lineage devel-
opmental progression.
MATERIALS AND METHODS
RNA purifi   cation, microarray analysis, and real-time RT-PCR. 
E2A-defi  cient HPCs were isolated from E2A-defi  cient bone marrow and 
cultured on S17 stromal cells in the presence of SCF, IL7, and Flt3L (R&D 
Systems), as described previously (37). E2A-defi  cient HPCs were transduced 
with E47ER retroviral vectors as described (37). Purifi  cation of hCD25+ 
cells was performed using MACS beads (Miltenyi Biotec). Total RNA was 
isolated using an RNeasy kit (Qiagen). Microarray analysis was performed 
in our core facility (BIOGEM). The Codelink microarrays were used in 
this analysis (BD Biosciences). For real-time PCR, cDNA synthesis was 
performed using Superscript III (Invitrogen) following the manufacturer’s 
protocol. Real-time PCR was performed using SYBR Green Master Mix 
(Stratagene) and analyzed by Mx4000 Instrumentation (Stratagene). The 
reactions were performed in triplicate at 95°C for 10 min, followed by 
40 cycles of 95°C for 30 s, 55°C for 1 min and 72°C for 30 s. The primer 
sequences used are: Hes1 forward, T  T  G  G  C  T  G  A  A  A  G  T  T  A  C  T  G  T  G  G   and 
rev A C  T  A  T  T  C  C  A  G  G  A  C  C  A  A  G  G  A  G  ; Hes5 forward T A  C  C  T  G  A  A  A  C  A  C-
A  G  C  A  A  A  G  C   and reverse G  C  T  G  G  A  G  T  G  G  T  A  A  G  C  A  G  ; Notch1 forward 
A  C  A  A  C  A  A  C  G  A  G  T  G  T  G  A  G  T  C  C   and reverse A  C  A  C  G  T  G  G  C  T  C  C  T  G  T-
A  T  A  T  G  ; Notch2 forward T  G  A  C  T  G  T  T  C  C  C  T  C  A  C  T  A  T  G  G   and reverse 
C  A  C  G  T  C  T  T  G  C  T  A  T  T  C  C  T  C  T  G  ; Notch3 forward A  G  A  T  C  A  A  T  G  A  G-
T  G  T  G  C  A  T  C  C   and reverse G  C  A  G  A  C  T  C  C  A  T  G  A  C  T  A  C  A  G  G  ; NumbL 
forward T  T  C  G  A  G  A  T  T  G  A  A  C  T  G  T  A  G  C  C   and reverse A  G  T  G  A  A  A  T  G  G-
T  T  C  C  C  T  T  A  G  C  ; Grg6 forward G  A  T  G  A  C  A  A  C  A  T  T  T  G  G  A  C  A  G  G   and 
reverse T  A  A  G  A  T  G  G  T  G  T  T  G  T  C  C  T  T  G  G  ; Grg3 forward T  G  A  G  A  A  G  A  A-
C  C  A  C  C  A  T  G  A  A  C   and reverse T  G  A  G  A  A  G  A  A  C  C  A  C  C  A  T  G  A  A  C  ; p-Tα 
forward C  T  G  C  A  A  C  T  G  G  G  T  C  A  T  G  C  T  T  C   and reverse T  C  A  G  A  G  G  G  G-
T  G  G  G  T  A  A  G  A  T  C  ; IL-7Rα forward T  T  A  C  T  T  C  A  A  A  G  G  C  T  T  C  T  G  G-
A  G   and reverse C  T  G  G  C  T  T  C  A  A  C  G  C  C  T  T  T  C  A  C  C  T  C  A  ; LAT forward 
A  G  A  A  T  G  T  G  G  A  T  G  C  A  G  A  T  G  A  G   and reverse C  G  T  A  A  T  C  T  T  C  A  C  A  C-
G  A  C  T  C  C  ; ARP forward C  G  A  C  C  T  G  G  A  A  G  T  C  C  A  A  C  T  A  C   and reverse 
A  T  C  T  G  C  T  G  C  A  T  C  T  G  C  T  T  G  .
OP9 cocultures and fl  ow cytometric analysis. OP9-GFP or OP9-DL1 
stromal cells were cultured in minimum essential medium alpha (MEMα; 
Invitrogen), supplemented with 10% fetal bovine serum (Gemini), 100 U/ml 
penicillin, 100 μg/ml streptomycin, and l-glutamine (Invitrogen), and 
plated 1 or 2 d before use in a 24-well plate, as described (20). The diff  eren-
tiation medium consisted of MEMα supplemented with 10% FCS (Gemini), 
50 μM 2-ME, 2 mM l-glutamine, 1 mM sodium pyruvate, 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 5 ng/ml IL-7, and 5 ng/ml Flt3L. Lineage 
marker (Lin)− progenitors isolated from E2A+/+, E2A+/−, and E2A−/− fetal 
liver by MACS purifi  cation were seeded in 1 ml of IL-7/Flt3L medium at 
105 cells/well of a 24-well plate. Various concentration of γ-secretase inhibi-
tor IX (Calbiochem) was added to the culture, as indicated (Fig. 6). At day 7 
of culture, cells were harvested and analyzed by fl   ow cytometry. FACS 
  analyses were performed as described (37). All antibodies were purchased 
from BD Biosciences or eBioscience.
Retroviral transduction and fetal thymic organ culture. Control 
MigR1 and ICN retroviral vectors were provided by M.J. Bevan (University 
of Washington, Seattle, WA). Retroviral transduction and fetal thymic organ 
culture were performed as described (6, 37). Lin− progenitors were isolated 
from E2A+/+ and E2A−/− fetal liver at day 14 of gestation and transduced 
with MigR1 and ICN retroviral vectors. After 24 h of transduction, 104 cells 
were cultured with a deoxyguanosine-treated fetal thymic lobe for 17 d. The 
culture medium was replaced by half every 5 d. The cells were harvested and 
analyzed for the expression of GFP, CD3, CD4, CD8, and NK1.1.
Luciferase assay. Luciferase reporter assay was performed as previously de-
scribed (59). The 3′E-Hes1 region was amplifi  ed with the primers: forward 
C  A  T  G  C  C  C  C  A  T  T  T  C  C  A  G  G  C  A  A  G   and reverse G  A  G  C  C  A  A  T  T  A  A  A  C  A-
A  A  A  C  A  A  A  . E2A-defi  cient HPCs were used for the transfection with the 
various luciferase constructs.
Chromatin histone immunoprecipitation. ChIP assays were per-
formed essentially as described (59). 107-fi  xed cells from mice carrying the 
E2AGFP fusion protein as well as wild-type thymus were lysed in SDS 
lysis buff  er (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, and 1% SDS) on 
ice for 10 min. The lysates were sonicated and diluted with 9 parts of 
50 mM Tris-HCl, pH 8.0, 167mM NaCl, 1.1% Triton X-100, and 0.11% 
sodium deoxycholate. 2 × 106 cells were used for each immunoprecipita-
tion. Full-length A.V. polyclonal antibody (BD Biosciences) was used to 
label E2AGFP-DNA complexes. Immunocomplexes were bound to protein 
G-Sepharose beads and washed four times. The immunocomplexes were 
then eluted by incubating the beads at 65°C overnight in 10 mM Tris-HCl 
(pH 8.0), 5 mM EDTA, 300 mM NaCl, and 0.5% SDS. Eluted DNA was 
treated with RNase A and digested with proteinase K. DNA was purifi  ed 
using the PCR Purifi  cation kit (Qiagen). PCR was performed with the 
following primers: forward G  G  G  T  T  G  T  C  T  C  G  G  G  T  T  T  C  A  G   and reverse 
C  A  G  G  G  C  T  C  G  T  G  G  T  T  T  T  C  A  T  .
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